Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-14-000086
Filing Date
2014-05-16
Accepted
2014-05-16 08:53:04
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cellcyteform10qmarch312014fi.htm 10-Q 236799
2 CERTIFICATION exhibit31.htm EX-31 12476
3 CERTIFICATION exhibit32.htm EX-32 5843
  Complete submission text file 0001056520-14-000086.txt   1385134

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20140331.xml EX-101.INS 134524
5 SCHEMA ccyg-20140331.xsd EX-101.SCH 10048
6 CALCULATION ccyg-20140331_cal.xml EX-101.CAL 15269
7 DEFINITION ccyg-20140331_def.xml EX-101.DEF 8137
8 LABELS ccyg-20140331_lab.xml EX-101.LAB 97893
9 PRESENTATION ccyg-20140331_pre.xml EX-101.PRE 73361
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 14849910
SIC: 2834 Pharmaceutical Preparations